The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape
Open accessPublished version of a preprint
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 20 of the 41 sources its claims cite were checked for support.
Abstract
The world continues to face a life-threatening viral pandemic. The virus underlying the Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has caused over 98 million confirmed cases and 2.2 million deaths since January 2020. Although the most recent respiratory viral pandemic swept the globe only a decade ago, the way science operates and responds to current events has experienced a cultural shift in the interim. The scientific community has responded rapidly to the COVID-19 pandemic, releasing over 125,000 COVID-19–related scientific articles within 10 months of the first confirmed case, of which more than 30,000 were hosted by preprint servers. We focused our analysis on bioRxiv and medRxiv, 2 growing preprint servers for biomedical research, investigating the attributes of COVID-19 preprints, their access and usage rates, as well as characteristics of their propagation on online platforms. Our data provide evidence for increased scientific and public engagement with preprints related to COVID-19 (COVID-19 preprints are accessed more, cited more, and shared more on various online platforms than non-COVID-19 preprints), as well as changes in the use of preprints by journalists and policymakers. We also find evidence for changes in preprinting and publishing behaviour: COVID-19 preprints are shorter and reviewed faster. Our results highlight the unprecedented role of preprints and preprint servers in the dissemination of COVID-19 science and the impact of the pandemic on the scientific communication landscape.
Overview
CoChat Summary
TL;DR
This paper analyzes bioRxiv and medRxiv preprints during the first 10 months of the COVID-19 pandemic, showing that COVID-19 preprints were posted in large numbers and accessed, cited, shared, and used in policy documents far more than non-COVID-19 preprints. It also finds that COVID-19 preprints were shorter and published in journals faster than non-COVID-19 preprints.
Key findings
- By October 31, 2020, over 125,000 COVID-19 publications had appeared, including 30,260 preprints (~25%); bioRxiv and medRxiv hosted 10,232 COVID-19 preprints in the first 10 months, compared with 78 Zika virus and 10 Ebola virus preprints on bioRxiv during those outbreaks.
- COVID-19 preprints on bioRxiv/medRxiv were accessed more (abstract views rate ratio = 18.2; PDF downloads rate ratio = 27.1), cited more (57.9% vs 21.5% received ≥1 citation; rate ratio = 13.7), tweeted more (98.9% vs 90.7% received >1 tweet; rate ratio = 7.6), covered in news more (28.7% vs 1.0%; rate ratio = 92.8), and commented on more (15.9% vs 3.1%; rate ratio = 11.0).
- COVID-19 preprints were 32% shorter than non-COVID-19 preprints (median 3,965 vs 5,427 words) and were published faster after posting (median 68 vs 116 days; 48-day difference); 21.1% of COVID-19 preprints were published by end of October vs 15.4% of non-COVID-19 preprints.
- Among COVID-19 corresponding authors, 85% were posting a bioRxiv/medRxiv preprint for the first time vs 69% of non-COVID-19 corresponding authors; 52 of 81 COVID-19 policy documents cited preprints, with medRxiv accounting for 209 of 255 preprint citations.
Methods
- Retrieved bioRxiv and medRxiv metadata via API through October 31, 2020 (N = 114,214 overall); comparative analysis used 44,503 preprints posted January–October 2020, of which 10,232 (23.0%) were classified as COVID-19 by keywords in titles/abstracts, plus a January–December 2019 control set (N = 30,094).
- Enhanced metadata with ROR affiliation matching, Crossref, Unpaywall, Dimensions citation data, Altmetric mentions, Disqus comment counts, and scraped bioRxiv/medRxiv usage data; policy analysis manually collected 81 COVID-19 and 38 non-COVID-19 policy documents.
- Used chi-squared tests, Mann–Whitney tests, Spearman correlations, time-adjusted negative binomial regressions, and 2-way ANOVAs with Tukey HSD post hoc comparisons.
Limitations
- Stated: COVID-19 classification relied on keyword matching of titles/abstracts at data extraction, so some early preprints revised to include COVID-19 keywords may have been captured; the tightly defined January–October 2020 window means preprints posted later had less time to accrue altmetric and usage metrics.
- Stated: policy document analysis was limited to a small set largely restricted to Europe, and whether preprint use in policy extends more globally remains to be explored; word and reference counts were limited to bioRxiv because medRxiv did not display full HTML texts.
- Evident: preprint publication status relied on bioRxiv/medRxiv DOI links and is likely an underestimate; Altmetric records only mentions it tracks, and missing responses were recorded as zero; the study is observational and does not establish causal effects of preprinting on later attention or publication outcomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
18 Valid · 1 Not valid · 14 Not checked · 141 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The COVID-19 crisis represents the first time that preprints have been widely used outside of specific communities to communicate during an epidemic.”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Introduction
What the sources say
- Not checked yetcites [13] Wellcome Trust. Sharing data during Zika and other global health emergencies | Wellcome. In: Wellcomeacuk [Internet]. 10 Feb 2016 [cited 13 May 2020]. Available from: https://wellcome.ac.uk/news/sharing-data-during-zika-and-other-global-health-emergencies
- Partly supportedcites [14] MA Johansson, 2018, An underutilized mechanism to accelerate outbreak science, PLoS Med sourceExperimental — accuracy not yet measured
The Summary points report that fewer than 5% of Ebola and Zika journal articles had been posted as preprints, and describe preprints as unfamiliar to many outside fields such as physics and statistics. That supports the claim’s contrast with earlier outbreaks. Published in 2018, the paper does not address preprint use during COVID-19 or establish that it was the first epidemic in which preprints were widely used outside those communities. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The fourth most tweeted COVID-19 preprint was a widely criticised (and later withdrawn) study linking the SARS-CoV-2 spike protein to HIV-1 glycoproteins [23].”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
What the sources say
- Supportedcites [23] P Pradhan, 2020, Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag, bioRxiv source
The source is the preprint identified in the citation: its title links the 2019-nCoV spike protein to HIV-1 gp120. The withdrawal notice (Abstract, no page) says the authors withdrew it in response to research-community comments on their approach and interpretation. The 'fourth most tweeted' ranking is the citing document’s characterization, not a finding attributed to this preprint. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“One of the primary concerns among authors around posting preprints is premature media coverage [16,31].”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Discussion
What the sources say
- Supportedcites [16] A Chiarelli, 2019, Scholarly Communication: An Exploratory Qualitative Study of Adoption, Practices, Drivers and Barriers, F1000Res source
In Results > Potential benefits and challenges of preprints (page not specified), the paper identifies media reporting of incorrect research as a frequently mentioned challenge and describes researchers’ concern that journalists could spread unreliable preprint findings. The Literature review (page not specified) explicitly describes the risk of uncertified science being reported prematurely in the media. (LLM, conf=0.88)
- Not matchedcites [31] ASAPbio. Preprint authors optimistic about benefits: preliminary results from the #bioPreprints2020 survey. In: ASAPbio [Internet]. 27 Jul 2020 [cited 1 Feb 2021]. Available from: https://asapbio.org/biopreprints2020-survey-initial-results
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many of the negative hashtags have been perpetuated by public figures such as the former President of America and the right-wing media [35,36].”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Discussion
What the sources say
- Partly supportedcites [35] U. Yaqub, 2021, Tweeting During the Covid-19 Pandemic: Sentiment Analysis of Twitter Messages by President Trump, Digit Gov Res Pract sourceExperimental — accuracy not yet measured
The Discussion reports that Trump repeatedly used “Chinese virus” in tweets and employed negative rhetoric about China. It does not establish that these were hashtags or address their perpetuation by right-wing media. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [36] A Gruzd, 2020, Going viral: How a single tweet spawned a COVID-19 conspiracy theory on Twitter, Big Data Soc source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study involving qualitative interviews of multiple research stakeholders found “early and rapid dissemination” to be among the most often cited benefits of preprints [16].”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Discussion
What the sources say
- Supportedcites [16] A Chiarelli, 2019, Scholarly Communication: An Exploratory Qualitative Study of Adoption, Practices, Drivers and Barriers, F1000Res source
The Methods (Analytical framework; page unavailable) report 38 semi-structured interviews with participants from multiple stakeholder groups. The Results (Potential benefits and challenges of preprints; page unavailable) identify early and rapid dissemination as the most frequently mentioned benefit. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
100 more claims · 6 with their cited sources checked
Create a free account to see all 174 claims and to verify the 2 references still open.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 47
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = 125reported p < .001 · recomputed p < .001
“z = 125.0, p < .001”
- Consistentz = 124.2reported p < .001 · recomputed p < .001
“z = 124.2, p < .001”
- Consistentz = 116.3reported p < .001 · recomputed p < .001
“z = 116.3, p < .001”
- Consistentz = 135.7reported p < .001 · recomputed p < .001
“z = 135.7, p < .001”
- Consistentz = 83.3reported p < .001 · recomputed p < .001
“z = 83.3, p < .001”
3 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
“we analysed the hashtags used in original tweets (i.e., excluding retweets) mentioning the top 100 most tweeted COVID-19 preprints (S4A Fig).”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Methods > Usage, altmetrics, and citation data
“we retrieved all tweets linking to the top 10 most-tweeted preprints.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > Attributes of COVID-19 preprints posted between January and October 2020
“The majority of preprints existed as only a single version for both COVID-19 and non-COVID-19 works, with very few preprints existing in more than 2 versions (Fig 2C).”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > Attributes of COVID-19 preprints posted between January and October 2020
“(C) License type chosen by authors. (D) Number of versions per preprint.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
“the most commented non-COVID-19 preprint received only 68 comments, whereas the most commented COVID-19 preprint had over 580 comments (Table 5).”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
“Table: Table 5 Top 10 most blogged COVID-19 preprints.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Methods > Preprint metadata for bioRxiv and medRxiv
“For a subset of preprints posted between September 1, 2019 and April 30, 2020 (N = 25,883), we enhanced the basic preprint metadata with data from a number of other sources, as outlined below.”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Methods > Preprint metadata for bioRxiv and medRxiv
“In total, we matched 54,289 preprints to a country (72.8%); for COVID-19 preprints alone, 6,692 preprints (65.4%) were matched to a country.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
“whereas 8 of the top 10 tweeted COVID-19 preprints were tweeted over 10,500 times each (Table 2).”
§ The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape > Results > COVID-19 preprints were shared and cited more widely than non-COVID-19 preprints
“| 10 | medRxiv | 10.1101/2020.03.30.20048165 | Association of BCG vaccination policy with prevalence and mortality of COVID-19 | April 6, 2020 | 10,701 | 7 | 0 |”
1 more finding
Create a free account to see every finding of this check.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Pradhan P, Pandey AK, Mishra A, Gupta P, Tripathi PK, Menon MB, et al. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. bioRxiv. 2020; 2020.01.30.927871. 10.1101/2020.01.30.927871 32511314”
Cited work 10.1101/2020.01.30.927871 · retracted 2020-02-02 · notice 10.1101/2020.01.30.927871 · this paper published 2021-04-02
Citations
Cites
1 retracted
Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag
Pradhan, P., Pandey, A. K., Mishra, A., Gupta, P., Tripathi, P. K., Menon, M. B., Gomes, J., Vivekanandan, P., & Kundu, B. (2020) · doi:10.1101/2020.01.30.927871 · Cited by 198
RetractedA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735 · cited 1×
“Although multiple coronaviruses are ubiquitous among humans and cause only mild disease, epidemics of newly emerging coronaviruses were previously observed in SARS in 2002 [5] and Middle East Respiratory Syndrome (MERS) in 2012 [6].”
BackgroundA Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344 · cited 1×
“Although multiple coronaviruses are ubiquitous among humans and cause only mild disease, epidemics of newly emerging coronaviruses were previously observed in SARS in 2002 [5] and Middle East Respiratory Syndrome (MERS) in 2012 [6].”
BackgroundKrämer, W. (2003) · Computational Statistics & Data Analysis · Cited by 1,858
COVID-19 antibody seroprevalence in santa clara county, california
Bendavid, E., Mulaney, B., Sood, N., Shah, S., Bromley-Dulfano, R., Lai, C., Weissberg, Z., Saavedra-Walker, R., Tedrow, J., Bogan, A., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab010 · Cited by 669 · cited 2×
“The most tweeted COVID-19 preprint (26,763 tweets) was a study investigating antibody seroprevalence in California [22].”
BackgroundInfluentialCOVID-19 Antibody Seroprevalence in Santa Clara County, CaliforniaPreprint
Bendavid, E., Mulaney, B., Sood, N., et al. (2020) · medRxiv · doi:10.1101/2020.04.14.20062463 · Cited by 559
Coronavirus: the spread of misinformation
Mian, A., & Khan, S. (2020) · BMC Medicine · doi:10.1186/s12916-020-01556-3 · Cited by 534
Research works printed but not linked: 5
- Kaiser J, 2014, Am 12:00. BioRxiv at 1 year: A promising start. In: Science | AAAS [Internet]. 11 Nov 2014 [cited 13 May 2020]. Available from: https://www.sciencemag.org/news/2014/11/biorxiv-1-year-promising-start
- D. Himmelstein, 2016, The licensing of bioRxiv preprints, Satoshi Village
- ASAPbio. Preprint authors optimistic about benefits: preliminary results from the #bioPreprints2020 survey. In: ASAPbio [Internet]. 27 Jul 2020 [cited 1 Feb 2021]. Available from: https://asapbio.org/biopreprints2020-survey-initial-results
- Inglis J. We’ve just put an additional, cautionary note about the use of preprints on every @biorxivpreprint https://t.co/08eSXL4dDi. In: Twitter [Internet]. 1 Feb 2020 [cited 22 May 2020]. Available from: https://twitter.com/johnringlis/status/1223598414493077505
- OASPA. COVID-19 Publishers Open Letter of Intent—Rapid Review. In: OASPA [Internet]. 27 May 2020 [cited 13 May 2020]. Available from: https://oaspa.org/covid-19-publishers-open-letter-of-intent-rapid-review/
Cited by
Items 501–554 of 554
COVID-19 SALGINI DÖNEMİNDE KORONAVİRÜS BİLİM KURULU’NUN BASIN DUYURULARININ DEĞERLENDİRİLMESİ
SARIYILDIZ, A. Y. (2025) · Dicle Üniversitesi Sosyal Bilimler Enstitüsü Dergisi · doi:10.15182/diclesosbed.1526163
Preparing for International and Cross‐Cultural Crises
Duncan, B., & Diers-Lawson, A. R. (2025) · Wiley eBooks · doi:10.1002/9781394180844.ch49
Adoption of Preprinting Across Scientific Disciplines and Geographical Regions (1991-2023)Preprint
Rzayeva, N., Pinfield, S., & Waltman, L. (2025) · SocArXiv (OSF Preprints) · doi:10.31235/osf.io/xdwc4_v2 · Cited by 5
Research Ethics and Integrity During Pandemics: Not Unique, but Vastly Magnified Challenges
Chatfield, K., & Singh, M. (2025) · SpringerBriefs in research and innovation governance · doi:10.1007/978-3-031-91324-2_1
Digitalisierung im Fokus der Subdisziplinen – Teil II: Bildgebung und Grundlagenwissenschaften
Schmitt, R., Winkels, H., Kelle, S., et al. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2566-7244
Liang, Z., Kuang, Y., Liang, G., Li, Z., & Jiang, M. (2025) · Cureus · doi:10.7759/cureus.85773
Open Science Practices in Integrated Assessment Models
Rodés-Bachs, C., Sampedro, J., Frilingou, N., Gardumi, F., & Giudice, C. L. (2025) · Open Research Europe · doi:10.12688/openreseurope.18824.1 · Cited by 3
The World of Academic Preprints: Promises and Pitfalls
Dutta, D., Kumar, M., & Sharma, M. (2025) · International Journal of Advanced Medical and Health Research · doi:10.4103/ijamr.ijamr_60_25
Wicke, R., Ratcliff, C. L., Fleerackers, A., Wang, Y., King, A. J., & Jensen, J. D. (2025) · Risk Analysis · doi:10.1111/risa.70071 · Cited by 2
“…about the nature of the new SARS-CoV-2 virus and effective pre-ventative measures, many scientists made their discoveries available as preprints (Fraser et al., 2021), and many jour-nalists reported these findings to the public—often without framing the science as unvetted or uncertain…”
Commentary: To bioRxiv or not to bioRxiv?
Lee, S. J., & Sung, J. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf090
Petronis, C., Roth, P. H., & Olteanu, A. (2025) · Information Communication & Society · doi:10.1080/1369118x.2025.2525487
“Within the first 10 months of the COVID-19 pandemic, about 150,000 research papers on SARS-CoV-2 and COVID-19 were published, many of which were made accessible (and cited) as preprints, before undergoing thorough peer review (Fraser et al., 2021).”
Revealing Dengue Dynamics: A Novel Bin-Wise Gaussian Process Model for Probabilistic ForecastingPreprint
Vieira, E. R., Mischaikow, K., Vivas, C. M. E. R., Gameiro, M., & Haque, U. (2025) · Research Square · doi:10.21203/rs.3.rs-6970265/v1
Open Access: In Between the Bright and the Dark Side
Alberton, P., Wiggenhauser, P. S., Möllhoff, N., Koban, K. C., & Giunta, R. E. (2025) · Handchirurgie · Mikrochirurgie · Plastische Chirurgie · doi:10.1055/a-2654-7594
Journalists reporting on the COVID-19 pandemic relied on research that had yet to be peer reviewed
Fleerackers, A., & Maggio, L. A. (2022) · doi:10.64628/aam.3an6nurwv
Exploring Public Relation Campaigns Research from 2019 to 2024: A Systematic Review
Abed, B. (2025) · Open Journal of Business and Management · doi:10.4236/ojbm.2025.135172
Preprints: A Novel Accelerator in Scientific Publishing
Masoudi, F. (2025) · Journal of Rafsanjan University of Medical Sciences · doi:10.61882/jrums.24.5.490
Using Preprint Sources in Science News: Do Transparent Disclosures Enhance Credibility?
Ratcliff, C. L., Fleerackers, A., Wicke, R., King, A. J., & Jensen, J. D. (2025) · Science Communication · doi:10.1177/10755470251363191 · Cited by 2
Canadian public health experiences during COVID-19: a new framework for assessing evidence
Cotton, C. S., LaBarge, M., & Nordstrom, A. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1620514 · Cited by 1
Open Access and Its Role in Realising SDG 3: Pathway to Health and Well Being
Upreti, H., Malhotra, R. K., Sharma, P., et al. (2025) · World sustainability series · doi:10.1007/978-3-031-99605-4_3
Application of artificial intelligence to overcome clinical information overload in cancer
Stenzl, A., Ghith, J., & Schijvenaars, B. J. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780192867636.003.0022
Revealing Dengue Dynamics: A Novel Bin-Wise Gaussian Process Model for Probabilistic ForecastingPreprint
Vieira, E. R., Mischaikow, K., Vivas, C. M. E. R., & Haque, U. (2025) · Research Square · doi:10.21203/rs.3.rs-6970265/v2
AI-Based Medical Imaging of COVID-19: A Visual and Textual Analysis of Scientific Literature
Zurlo, G., & Ronchieri, E. (2025) · EAI/Springer Innovations in Communication and Computing · doi:10.1007/978-3-031-96518-0_21
Quincho-Lopez, A. (2025) · International Journal for Educational Integrity · doi:10.1007/s40979-025-00205-7
“First, preprints were not considered, even though they were a means of important and rapid dissemination of valuable information amid the threat of the pandemic, especially in the early phase (Fraser et al. 2021).”
Geography of Research Activities and Urban Hierarchies
Maisonobe, M. (2025) · doi:10.1002/9781394388578.ch4
Torrico, D. V., & Prado, D. M. (2025) · Estudios sobre el Mensaje Periodístico · doi:10.5209/esmp.103839
Expertise scientifique, débat public et décisions de sécurité sanitaire
Oualikene-Gonin, W., Castel, P., Paccaud, F., Maison, P., & Ankri, J. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2025.10.014
Volume isn't openness: misaligned assessment and Open Science adoption in Ecuador
Guerra, J., Naranjo-Toro, M., & Basantes-Andrade, A. (2026) · Frontiers in Research Metrics and Analytics · doi:10.3389/frma.2025.1707881
When peer review drags on: the harm to early career researchers
Felisi, N. M., Vecchio, R., & Odone, A. (2026) · Frontiers in Research Metrics and Analytics · doi:10.3389/frma.2026.1740381 · Cited by 3
Martínez, Á. C. G., & González, A. D. L. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1278640
Kwongo, J. W. M., & Chatgpt, C. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6304757
Kwongo, J. W. M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6362173
Kwongo, J. W. M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6368076 · Cited by 2
Yang, D. (2026) · International Journal of Human-Computer Interaction · doi:10.1080/10447318.2026.2633737
Les données ouvertes au service de l’économie de la santé : l’expérience de l’enquête SHARE
Jusot, F., & Renaud, T. (2026) · Revue économique · doi:10.3917/reco.765.0773
Olaiya, V. O., Ejeheri, F. O., Adjei, A. B., Agyekum, V. K., Omotoso, T. A., Akitoye, A. B., Eze, M. C., Imalele, N., Akandor, F. Y., Najneen, F., et al. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02312-z
Tönsfeuerborn, T., Hauck, K., Volle, J., & Kaldewey, D. (2026) · Humanities and Social Sciences Communications · doi:10.1057/s41599-026-07033-1
Approche de la controverse médicale par les sciences sociales
Roussel, Y. (2021) · theses.fr (ABES) · doi:10.70675/bee49ad0z47dcz4cc1z97bcze70a0a7608ee
Integration of various types of information in living systematic reviews
Davidson, M. (2024) · theses.fr (ABES) · doi:10.70675/a60f5802z1fb9z4866z9e22z7be74c96be25
Meier, P., Boland, K., Kallmeyer, L., & Dietze, S. (2026) · ACM Web Science Conference (WebSci) · doi:10.1145/3795513.3810448
“Furthermore, increasing public interest has also led to a dissolution of the traditional scientific knowledge order as recent work has shown [13, 40], leading to oversimplification or politicization of scientific findings.”
Funding Independent Scientific Publications: The Third Option
Oakley, R. M. E., Atia, A. E., & Elmuttardi, K. K. (2026) · Journal of The Best Available Evidence in Medicine · doi:10.63720/v2i1004
Holbert, R. L., Bowman, N. D., & Walter, N. (2026) · De Gruyter eBooks · doi:10.1515/9783111087139-004
Premji, Z., McGill, S., & Riegelman, A. (2026) · Research Synthesis Methods · doi:10.1017/rsm.2026.10101 · Cited by 1
Kotsis, K. (2026) · Journal of Contemporary Philosophical and Anthropological Studies · doi:10.59652/p2hq0781
“The COVID-19 pandemic, for example, underscored the importance of accelerating access to emerging scientific evidence, particularly in contexts where delays in publication could have direct consequences for public health outcomes (Fraser et al., 2021; Škorić et al., 2020 ).”
Naganawa, S., Ito, R., & Taoka, T. (2026) · Japanese Journal of Radiology · doi:10.1007/s11604-026-02046-x
“During the COVID-19 pandemic, preprints showed both their social value and their risks [8].”
Fabricated references are twice as common in medRxiv preprints as in peer‐reviewed articles
Topaz, M., Zhang, Z., Gupta, P., Roguin, N., & Peltonen, L. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70139 · Cited by 1
Schönwolff, M., & Müller, R. (2026) · Research Evaluation · doi:10.1093/reseval/rvag032 · Cited by 1
How preprints accelerate the time to first citation of the subsequent journal articles?
Tian, D., & Li, J. (2026) · Scientometrics · doi:10.1007/s11192-026-05758-z
“…and SSRN allow researchers to establish priority (Bourne et al., 2017), solicit early feedback (Anderson, 2020), and accelerate the dissemination of scientific discoveries (Ni & Waltman, 2024)—a value dramatically exemplified during the COVID-19 pandemic (Fraser et al., 2021; Rzayeva et al., 2023).”
Mejia, C. (2026) · Springer eBooks · doi:10.1007/978-981-95-7020-1_10
Supporting open science practices at multidisciplinary scale
Soper, D., Cadwallader, L., & Hrynaszkiewicz, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355163
“Much of this improvement occurred before the COVID-19 pandemic, which heralded increased scientific and public engagement with preprints [8], suggesting that the preprint sharing solutions implemented at PLOS One did initially help to drive adoption.”
Rho, J., Sheu, J., Forbes, A., et al. (2026) · npj Science of Learning · doi:10.1038/s41539-026-00449-z
“Open science practices have been found to foster greater collaboration, accelerate discovery, and ensure that scienti fi c knowledge bene fi ts a broader audience 2,3 .”
Communication as leadership: adaptive communicative leadership in public health mega-crises
Hasselström, A. E., Nour, M. M., Diers-Lawson, A. R., et al. (2026) · Frontiers in Communication · doi:10.3389/fcomm.2026.1868921
Kim, D. H., Jeon, K., & You, S. C. (2026) · Journal of Evidence-Based Practice · doi:10.63528/jebp.2026.00007
Kurmanbek, Y., Ibrayeva, Z., & Warditz, V. (2026) · Frontiers in Education · doi:10.3389/feduc.2026.1949866
Metadata
- Authors
- Fraser, N., Brierley, L., Dey, G., Polka, J. K., Pálfy, M., Nanni, F., & Coates, J. A.
- Affiliations
- ZBW – Leibniz-Informationszentrum Wirtschaft (DE)
- University of Liverpool (GB)
- MRC Laboratory for Molecular Cell Biology (GB)
- ASAPbio (US)
- Company of Biologists (GB)
- The Alan Turing Institute (GB)
- Queen Mary University of London (GB)
- Corresponding author
- Coates, Jonathon Alexis
- ORCID
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-02
- Volume
- 19
- Issue
- 4
- Pages
- e3000959
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC8046348
- OpenAlex
- W3150044582
- Cited by
- 555
- References
- 49
- Citations by year
- 2026: 30 · 2025: 61 · 2024: 86 · 2023: 128 · 2022: 129 · 2021: 96
- FWCI
- 94.62
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-04-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ZBW Publication Archive (ZBW – Leibniz Information Centre for Economics) (acceptedVersion, cc-by)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Funders
- OASE (01PU17005B, 01PU17011D)
- Medical Research Council (MR/T027355/1)
- Topics
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- preprints, COVID-19 research, preprint servers, bioRxiv, medRxiv, science communication, SARS-CoV-2, public engagement with science
- MeSH terms
- Preprints as Topic, COVID-19, SARS-CoV-2, Communication, Humans, Publishing, Peer Review, Research, Information Dissemination, Biomedical Research, Pandemics, Open Access Publishing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.